Immunoaffinity method to identify aggregin, a putative ADP-receptor in human blood platelets.
The ADP-receptor on the surface of human platelets and cells of megakaryocytic lineage has been classified as P2T purinergic receptor for which ADP is an agonist and ATP is an antagonist. Although it is one of the earliest identified of the important cellular receptors, it has neither been purified nor cloned. We have developed an immunoaffinity method for rapidly identifying the platelet ADP-receptor and this method can be extended to the purification of the receptor. A polyclonal antibody to glutamate dehydrogenase (GDH) covalently modified by 5'-p-fluorosulfonylbenzoyladenosine (FSBA) recognized neither FSBA nor glutamate dehydrogenase. Immunoblot of the gel obtained by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of solubilized FSBA-labeled platelets showed the presence of a protein band at 100 kDa and this band was absent in the immunoblots of platelets that were preincubated with ADP and ATP or covalently modified by the chemically reactive ADP-affinity analogs, 2- and 8-(4-bromo-2,3-dioxobutylthio)adenosine-5'-diphosphate (2- and 8BDB-TADP) and 2-(3-bromo-2-oxopropylthio)adenosine-5'-diphosphate (2-BOP-TADP), prior to treatment with FSBA. FSBA as well as 2- and 8-BDB-TADP and 2-BOP-TADP have been previously shown to inhibit ADP-induced platelet responses by selectively and covalently modifying aggregin (100 kDa), an ADP-receptor in intact human blood platelets. The results show that polyclonal antibody to FSBA-labeled GDH is capable of recognizing FSBA-labeled aggregin on platelets and, thus, could be used to purify aggregin by immunoaffinity column chromatography. The immunoaffinity method was found to be far more sensitive than the radiochemical methods to identify aggregin previously developed in our laboratory. Since FSBA is also capable of reacting with enzymes that require ATP for their catalytic function, the polyclonal antibody may be used to identify and purify other P2-type purinergic receptors that require binding of ATP before eliciting cellular responses.
Puri
R N
RN
Sol Sherry Thrombosis Research Center, Temple University School of Medicine, 3400 N. Broad Street, Philadelphia, Pennsylvania 19140, USA.
Colman
R W
RW
D000241:Adenosine / Q000031:analogs & derivatives / Q000276:immunology / Q000378:metabolism; D000345:Affinity Labels; D000918:Antibody Specificity; D001792:Blood Platelets / Q000737:chemistry*; D005969:Glutamate Dehydrogenase / Q000276:immunology; D006801:Humans; D015151:Immunoblotting / Q000379:methods*; D010980:Platelet Membrane Glycoproteins / Q000302:isolation & purification*; D018048:Receptors, Purinergic P2 / Q000302:isolation & purification*
D000345:Affinity Labels; D010980:Platelet Membrane Glycoproteins; D018048:Receptors, Purinergic P2; C055422:aggregin; C010959:5'-(4-fluorosulfonylbenzoyl)adenosine; D005969:Glutamate Dehydrogenase; D000241:Adenosine